Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 7.61% |
AMGEN INC. | AMGN | 6.22% |
GILEAD SCIENCES, INC. | GILD | 4.34% |
REGENERON PHARMACEUTICALS | REGN | 4.12% |
VERTEX PHARMACEUTICALS | VRTX | 3.94% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.05% |
CORTEVA INC | CTVA | 2.75% |
MODERNA INC | MRNA | 2.64% |
ASTRAZENECA PLC ADR | AZN | 2.45% |
BIOGEN IDEC, INC. | BIIB | 2.44% |
ILLUMINA INC | ILMN | 2.08% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.78% |
UNITED THERAPEUTICS CORP | UTHR | 1.76% |
SAREPTA THERAPEU | SRPT | 1.72% |
INSMED INC | INSM | 1.72% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.72% |
VIATRIS INC | VTRS | 1.68% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.66% |
NATERA INC | NTRA | 1.61% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.59% |
INCYTE CORP | INCY | 1.54% |
EXACT SCIENCES | EXAS | 1.44% |
ARGENX SE - ADR | ARGX | 1.41% |
MEDPACE HOLDINGS | MEDP | 1.32% |
INTRA-CELLULAR T | ITCI | 1.31% |
REVOLUTION MEDICINES INC | RVMD | 1.28% |
HALOZYME THERAPEUTICS INC | HALO | 1.22% |
IONIS PHARMACEUTICALS, IN | IONS | 1.22% |
ALKERMES PLC | ALKS | 1.21% |
VAXCYTE INC | PCVX | 1.17% |
CYTOKINETICS INC | CYTK | 1.14% |
EXELIXIS, INC. | EXEL | 1.13% |
CRISPR THERAPEUTICS AG | CRSP | 1.13% |
VIKING THERAPEUTICS INC | VKTX | 1.11% |
ROIVANT SCIENCES LTD | ROIV | 1.07% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.07% |
BLUEPRINT MEDICI | BPMC | 0.96% |
CRINETICS PHARMACEUTICALS | CRNX | 0.95% |
GUARDANT HEALTH INC | GH | 0.91% |
TG THERAPEUTICS | TGTX | 0.90% |
BIONTECH SE-ADR | BNTX | 0.90% |
BRIDGEBIO PHARMA INC | BBIO | 0.88% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.88% |
AXSOME THERAPEUT | AXSM | 0.87% |
ULTRAGENYX PHARM | RARE | 0.84% |
APELLIS PHARMACE | APLS | 0.84% |
PROTHENA CORP PL | PRTA | 0.81% |
CEREVEL THERAPEUTICS HOLD | CERE | 0.80% |
TWIST BIOSCIENCE CORP | TWST | 0.78% |
AMICUS THERAPEUTICS INC | FOLD | 0.78% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.73% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.73% |
KRYSTAL BIOTECH INC | KRYS | 0.71% |
INTELLIA THERAPE | NTLA | 0.70% |
NOVAVAX INC | NVAX | 0.69% |
IMMUNOVANT INC | IMVT | 0.67% |
BEAM THERAPEUTICS INC | BEAM | 0.63% |
PTC THERAPEUTICS | PTCT | 0.62% |
AKERO THERAPEUTICS INC | AKRO | 0.60% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.59% |
NUVALENT INC-A | NUVL | 0.58% |
RECURSION PHARMACEUTICALS | RXRX | 0.55% |
MADRIGAL PHARMAC | MDGL | 0.55% |
ARDELYX INC | ARDX | 0.51% |
DYNAVAX TECHNOLOGY | DVAX | 0.50% |
IRONWOOD PHARMAC | IRWD | 0.45% |
SAGE THERAPEUTIC | SAGE | 0.34% |
PACIFIC BIOSCIEN | PACB | 0.19% |
GRAIL INC | GRAL | 0.05% |
Other (Cash, derivatives and other liabilities) | 0.86% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.